International Journal of General Medicine-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2272515, encodeId=147822e2515db, content=不接收case reports, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Tue Jul 08 14:49:04 CST 2025, time=2025-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2199793, encodeId=3b752199e939f, content=18号投的，目前1A_1 - INITIAL ASSESSMENT IN PROGRESS，大家投稿状态多久才变？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2361732147, createdName=呆子550, createdTime=Mon Apr 22 16:25:49 CST 2024, time=2024-04-22, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2176797, encodeId=f3fd21e6797fe, content=1A1状态5天了，什么时候能有变化呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=45e52538960, createdName=1251953cm97(暂无昵称), createdTime=Sun Dec 24 08:01:07 CST 2023, time=2023-12-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2239326, encodeId=5fb7223932682, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;放疗 经验分享：17 August 2024 Peer review selection 17 September 2024 First peer reviewer allocated 27 September 2024 First report returned 30 September 2024 Second or more peer reviewer reports returned 11 October 2024 Report sent to the Editor-in-Chief 26 October 2024 Report: revise with changes 31 October 2024 Resubmission pending 13 November 2024 Resubmitted manuscript received 22 November 2024 Processing revised manuscript 22 November 2024 Peer reviewer(s) second round ......审稿一个月，给了3周小修，返回去没几天就Accept。口碑OK，非预警，审稿人非常专业和谨慎，提问细致且内行。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8c171373773, createdName=gzhjjx, createdTime=Tue Nov 26 15:32:47 CST 2024, time=2024-11-26, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2204834, encodeId=958f22048341c, content=偏重的研究方向：临床研究 经验分享：3月26号投的现在还在1A2，大家进度都咋样了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0859239868, createdName=ms9000001639670421, createdTime=Wed May 15 14:40:55 CST 2024, time=2024-05-15, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2210737, encodeId=0a0d2210e3795, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤学 经验分享：大家别投了，一审56天，编辑给我发消息了，我投了1个月还是1A1，想换杂志了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210303/c8f4595dadea4266aa1532bb03641b54/0826761e11894dafafe181f2cae69424.jpg, createdBy=1b7c5246256, createdName=烂医生, createdTime=Thu Jun 20 00:28:44 CST 2024, time=2024-06-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2144927, encodeId=d2e2214492ea2, content=请问大家1a状态持续了3周是为什么啊？2周前收到杂志社邮件说投稿量大，编辑初始审查延长2周，现在2周已经过了，1a一点动静也没有，是为什么呢？有一样的宝子不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7105612032, createdName=ms6000001074362839, createdTime=Tue Jun 27 00:55:47 CST 2023, time=2023-06-27, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2204108, encodeId=047d22041082e, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤;生信 经验分享：审稿慢的要命，我去年年底投的，2月份送审，2月10跟我说第一个意见回来，到现在第二个意见都没回，催稿两次了都是敷衍，已经不想等了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4899118028, createdName=ms6000000944001270, createdTime=Sat May 11 16:03:12 CST 2024, time=2024-05-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2189277, encodeId=a7a521892e76e, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：这个返修回去需要多久有消息呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07ce6584759, createdName=ms4000001373859908, createdTime=Sun Feb 25 14:52:59 CST 2024, time=2024-02-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1075726, encodeId=c02510e5726fa, content=4BD - PROCESSING REVISED MANUSCRIPT这状态三天了，不知道为啥不进行到下一状态，有人知道大修返回去几天能有结果呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=df1d5308328, createdName=雨中龙, createdTime=Wed Dec 01 08:19:50 CST 2021, time=2021-12-01, status=1, ipAttribution=)]

2025-07-08 匿名用户

不接收case reports

3 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2272515, encodeId=147822e2515db, content=不接收case reports, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Tue Jul 08 14:49:04 CST 2025, time=2025-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2199793, encodeId=3b752199e939f, content=18号投的，目前1A_1 - INITIAL ASSESSMENT IN PROGRESS，大家投稿状态多久才变？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2361732147, createdName=呆子550, createdTime=Mon Apr 22 16:25:49 CST 2024, time=2024-04-22, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2176797, encodeId=f3fd21e6797fe, content=1A1状态5天了，什么时候能有变化呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=45e52538960, createdName=1251953cm97(暂无昵称), createdTime=Sun Dec 24 08:01:07 CST 2023, time=2023-12-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2239326, encodeId=5fb7223932682, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;放疗 经验分享：17 August 2024 Peer review selection 17 September 2024 First peer reviewer allocated 27 September 2024 First report returned 30 September 2024 Second or more peer reviewer reports returned 11 October 2024 Report sent to the Editor-in-Chief 26 October 2024 Report: revise with changes 31 October 2024 Resubmission pending 13 November 2024 Resubmitted manuscript received 22 November 2024 Processing revised manuscript 22 November 2024 Peer reviewer(s) second round ......审稿一个月，给了3周小修，返回去没几天就Accept。口碑OK，非预警，审稿人非常专业和谨慎，提问细致且内行。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8c171373773, createdName=gzhjjx, createdTime=Tue Nov 26 15:32:47 CST 2024, time=2024-11-26, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2204834, encodeId=958f22048341c, content=偏重的研究方向：临床研究 经验分享：3月26号投的现在还在1A2，大家进度都咋样了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0859239868, createdName=ms9000001639670421, createdTime=Wed May 15 14:40:55 CST 2024, time=2024-05-15, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2210737, encodeId=0a0d2210e3795, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤学 经验分享：大家别投了，一审56天，编辑给我发消息了，我投了1个月还是1A1，想换杂志了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210303/c8f4595dadea4266aa1532bb03641b54/0826761e11894dafafe181f2cae69424.jpg, createdBy=1b7c5246256, createdName=烂医生, createdTime=Thu Jun 20 00:28:44 CST 2024, time=2024-06-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2144927, encodeId=d2e2214492ea2, content=请问大家1a状态持续了3周是为什么啊？2周前收到杂志社邮件说投稿量大，编辑初始审查延长2周，现在2周已经过了，1a一点动静也没有，是为什么呢？有一样的宝子不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7105612032, createdName=ms6000001074362839, createdTime=Tue Jun 27 00:55:47 CST 2023, time=2023-06-27, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2204108, encodeId=047d22041082e, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤;生信 经验分享：审稿慢的要命，我去年年底投的，2月份送审，2月10跟我说第一个意见回来，到现在第二个意见都没回，催稿两次了都是敷衍，已经不想等了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4899118028, createdName=ms6000000944001270, createdTime=Sat May 11 16:03:12 CST 2024, time=2024-05-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2189277, encodeId=a7a521892e76e, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：这个返修回去需要多久有消息呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07ce6584759, createdName=ms4000001373859908, createdTime=Sun Feb 25 14:52:59 CST 2024, time=2024-02-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1075726, encodeId=c02510e5726fa, content=4BD - PROCESSING REVISED MANUSCRIPT这状态三天了，不知道为啥不进行到下一状态，有人知道大修返回去几天能有结果呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=df1d5308328, createdName=雨中龙, createdTime=Wed Dec 01 08:19:50 CST 2021, time=2021-12-01, status=1, ipAttribution=)]

2024-04-22 呆子550 来自内蒙古

18号投的，目前1A_1 - INITIAL ASSESSMENT IN PROGRESS，大家投稿状态多久才变？

88 3 举报

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2272515, encodeId=147822e2515db, content=不接收case reports, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Tue Jul 08 14:49:04 CST 2025, time=2025-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2199793, encodeId=3b752199e939f, content=18号投的，目前1A_1 - INITIAL ASSESSMENT IN PROGRESS，大家投稿状态多久才变？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2361732147, createdName=呆子550, createdTime=Mon Apr 22 16:25:49 CST 2024, time=2024-04-22, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2176797, encodeId=f3fd21e6797fe, content=1A1状态5天了，什么时候能有变化呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=45e52538960, createdName=1251953cm97(暂无昵称), createdTime=Sun Dec 24 08:01:07 CST 2023, time=2023-12-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2239326, encodeId=5fb7223932682, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;放疗 经验分享：17 August 2024 Peer review selection 17 September 2024 First peer reviewer allocated 27 September 2024 First report returned 30 September 2024 Second or more peer reviewer reports returned 11 October 2024 Report sent to the Editor-in-Chief 26 October 2024 Report: revise with changes 31 October 2024 Resubmission pending 13 November 2024 Resubmitted manuscript received 22 November 2024 Processing revised manuscript 22 November 2024 Peer reviewer(s) second round ......审稿一个月，给了3周小修，返回去没几天就Accept。口碑OK，非预警，审稿人非常专业和谨慎，提问细致且内行。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8c171373773, createdName=gzhjjx, createdTime=Tue Nov 26 15:32:47 CST 2024, time=2024-11-26, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2204834, encodeId=958f22048341c, content=偏重的研究方向：临床研究 经验分享：3月26号投的现在还在1A2，大家进度都咋样了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0859239868, createdName=ms9000001639670421, createdTime=Wed May 15 14:40:55 CST 2024, time=2024-05-15, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2210737, encodeId=0a0d2210e3795, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤学 经验分享：大家别投了，一审56天，编辑给我发消息了，我投了1个月还是1A1，想换杂志了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210303/c8f4595dadea4266aa1532bb03641b54/0826761e11894dafafe181f2cae69424.jpg, createdBy=1b7c5246256, createdName=烂医生, createdTime=Thu Jun 20 00:28:44 CST 2024, time=2024-06-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2144927, encodeId=d2e2214492ea2, content=请问大家1a状态持续了3周是为什么啊？2周前收到杂志社邮件说投稿量大，编辑初始审查延长2周，现在2周已经过了，1a一点动静也没有，是为什么呢？有一样的宝子不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7105612032, createdName=ms6000001074362839, createdTime=Tue Jun 27 00:55:47 CST 2023, time=2023-06-27, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2204108, encodeId=047d22041082e, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤;生信 经验分享：审稿慢的要命，我去年年底投的，2月份送审，2月10跟我说第一个意见回来，到现在第二个意见都没回，催稿两次了都是敷衍，已经不想等了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4899118028, createdName=ms6000000944001270, createdTime=Sat May 11 16:03:12 CST 2024, time=2024-05-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2189277, encodeId=a7a521892e76e, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：这个返修回去需要多久有消息呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07ce6584759, createdName=ms4000001373859908, createdTime=Sun Feb 25 14:52:59 CST 2024, time=2024-02-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1075726, encodeId=c02510e5726fa, content=4BD - PROCESSING REVISED MANUSCRIPT这状态三天了，不知道为啥不进行到下一状态，有人知道大修返回去几天能有结果呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=df1d5308328, createdName=雨中龙, createdTime=Wed Dec 01 08:19:50 CST 2021, time=2021-12-01, status=1, ipAttribution=)]

2023-12-24 1251953cm97(暂无昵称) 来自北京

1A1状态5天了，什么时候能有变化呀

132 4 举报

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2272515, encodeId=147822e2515db, content=不接收case reports, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Tue Jul 08 14:49:04 CST 2025, time=2025-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2199793, encodeId=3b752199e939f, content=18号投的，目前1A_1 - INITIAL ASSESSMENT IN PROGRESS，大家投稿状态多久才变？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2361732147, createdName=呆子550, createdTime=Mon Apr 22 16:25:49 CST 2024, time=2024-04-22, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2176797, encodeId=f3fd21e6797fe, content=1A1状态5天了，什么时候能有变化呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=45e52538960, createdName=1251953cm97(暂无昵称), createdTime=Sun Dec 24 08:01:07 CST 2023, time=2023-12-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2239326, encodeId=5fb7223932682, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;放疗 经验分享：17 August 2024 Peer review selection 17 September 2024 First peer reviewer allocated 27 September 2024 First report returned 30 September 2024 Second or more peer reviewer reports returned 11 October 2024 Report sent to the Editor-in-Chief 26 October 2024 Report: revise with changes 31 October 2024 Resubmission pending 13 November 2024 Resubmitted manuscript received 22 November 2024 Processing revised manuscript 22 November 2024 Peer reviewer(s) second round ......审稿一个月，给了3周小修，返回去没几天就Accept。口碑OK，非预警，审稿人非常专业和谨慎，提问细致且内行。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8c171373773, createdName=gzhjjx, createdTime=Tue Nov 26 15:32:47 CST 2024, time=2024-11-26, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2204834, encodeId=958f22048341c, content=偏重的研究方向：临床研究 经验分享：3月26号投的现在还在1A2，大家进度都咋样了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0859239868, createdName=ms9000001639670421, createdTime=Wed May 15 14:40:55 CST 2024, time=2024-05-15, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2210737, encodeId=0a0d2210e3795, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤学 经验分享：大家别投了，一审56天，编辑给我发消息了，我投了1个月还是1A1，想换杂志了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210303/c8f4595dadea4266aa1532bb03641b54/0826761e11894dafafe181f2cae69424.jpg, createdBy=1b7c5246256, createdName=烂医生, createdTime=Thu Jun 20 00:28:44 CST 2024, time=2024-06-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2144927, encodeId=d2e2214492ea2, content=请问大家1a状态持续了3周是为什么啊？2周前收到杂志社邮件说投稿量大，编辑初始审查延长2周，现在2周已经过了，1a一点动静也没有，是为什么呢？有一样的宝子不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7105612032, createdName=ms6000001074362839, createdTime=Tue Jun 27 00:55:47 CST 2023, time=2023-06-27, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2204108, encodeId=047d22041082e, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤;生信 经验分享：审稿慢的要命，我去年年底投的，2月份送审，2月10跟我说第一个意见回来，到现在第二个意见都没回，催稿两次了都是敷衍，已经不想等了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4899118028, createdName=ms6000000944001270, createdTime=Sat May 11 16:03:12 CST 2024, time=2024-05-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2189277, encodeId=a7a521892e76e, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：这个返修回去需要多久有消息呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07ce6584759, createdName=ms4000001373859908, createdTime=Sun Feb 25 14:52:59 CST 2024, time=2024-02-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1075726, encodeId=c02510e5726fa, content=4BD - PROCESSING REVISED MANUSCRIPT这状态三天了，不知道为啥不进行到下一状态，有人知道大修返回去几天能有结果呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=df1d5308328, createdName=雨中龙, createdTime=Wed Dec 01 08:19:50 CST 2021, time=2021-12-01, status=1, ipAttribution=)]

2024-11-26 gzhjjx 来自贵州省

审稿速度:1.0 | 投稿命中率:75.0
偏重的研究方向：肿瘤;放疗
经验分享：17 August 2024 Peer review selection
17 September 2024 First peer reviewer allocated
27 September 2024 First report returned
30 September 2024 Second or more peer reviewer reports returned
11 October 2024 Report sent to the Editor-in-Chief
26 October 2024 Report: revise with changes
31 October 2024 Resubmission pending
13 November 2024 Resubmitted manuscript received
22 November 2024 Processing revised manuscript
22 November 2024 Peer reviewer(s) second round
......审稿一个月，给了3周小修，返回去没几天就Accept。口碑OK，非预警，审稿人非常专业和谨慎，提问细致且内行。

70 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2272515, encodeId=147822e2515db, content=不接收case reports, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Tue Jul 08 14:49:04 CST 2025, time=2025-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2199793, encodeId=3b752199e939f, content=18号投的，目前1A_1 - INITIAL ASSESSMENT IN PROGRESS，大家投稿状态多久才变？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2361732147, createdName=呆子550, createdTime=Mon Apr 22 16:25:49 CST 2024, time=2024-04-22, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2176797, encodeId=f3fd21e6797fe, content=1A1状态5天了，什么时候能有变化呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=45e52538960, createdName=1251953cm97(暂无昵称), createdTime=Sun Dec 24 08:01:07 CST 2023, time=2023-12-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2239326, encodeId=5fb7223932682, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;放疗 经验分享：17 August 2024 Peer review selection 17 September 2024 First peer reviewer allocated 27 September 2024 First report returned 30 September 2024 Second or more peer reviewer reports returned 11 October 2024 Report sent to the Editor-in-Chief 26 October 2024 Report: revise with changes 31 October 2024 Resubmission pending 13 November 2024 Resubmitted manuscript received 22 November 2024 Processing revised manuscript 22 November 2024 Peer reviewer(s) second round ......审稿一个月，给了3周小修，返回去没几天就Accept。口碑OK，非预警，审稿人非常专业和谨慎，提问细致且内行。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8c171373773, createdName=gzhjjx, createdTime=Tue Nov 26 15:32:47 CST 2024, time=2024-11-26, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2204834, encodeId=958f22048341c, content=偏重的研究方向：临床研究 经验分享：3月26号投的现在还在1A2，大家进度都咋样了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0859239868, createdName=ms9000001639670421, createdTime=Wed May 15 14:40:55 CST 2024, time=2024-05-15, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2210737, encodeId=0a0d2210e3795, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤学 经验分享：大家别投了，一审56天，编辑给我发消息了，我投了1个月还是1A1，想换杂志了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210303/c8f4595dadea4266aa1532bb03641b54/0826761e11894dafafe181f2cae69424.jpg, createdBy=1b7c5246256, createdName=烂医生, createdTime=Thu Jun 20 00:28:44 CST 2024, time=2024-06-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2144927, encodeId=d2e2214492ea2, content=请问大家1a状态持续了3周是为什么啊？2周前收到杂志社邮件说投稿量大，编辑初始审查延长2周，现在2周已经过了，1a一点动静也没有，是为什么呢？有一样的宝子不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7105612032, createdName=ms6000001074362839, createdTime=Tue Jun 27 00:55:47 CST 2023, time=2023-06-27, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2204108, encodeId=047d22041082e, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤;生信 经验分享：审稿慢的要命，我去年年底投的，2月份送审，2月10跟我说第一个意见回来，到现在第二个意见都没回，催稿两次了都是敷衍，已经不想等了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4899118028, createdName=ms6000000944001270, createdTime=Sat May 11 16:03:12 CST 2024, time=2024-05-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2189277, encodeId=a7a521892e76e, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：这个返修回去需要多久有消息呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07ce6584759, createdName=ms4000001373859908, createdTime=Sun Feb 25 14:52:59 CST 2024, time=2024-02-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1075726, encodeId=c02510e5726fa, content=4BD - PROCESSING REVISED MANUSCRIPT这状态三天了，不知道为啥不进行到下一状态，有人知道大修返回去几天能有结果呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=df1d5308328, createdName=雨中龙, createdTime=Wed Dec 01 08:19:50 CST 2021, time=2021-12-01, status=1, ipAttribution=)]

2024-05-15 ms9000001639670421 来自江西省

偏重的研究方向：临床研究
经验分享：3月26号投的现在还在1A2，大家进度都咋样了？

101 4 举报

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2272515, encodeId=147822e2515db, content=不接收case reports, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Tue Jul 08 14:49:04 CST 2025, time=2025-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2199793, encodeId=3b752199e939f, content=18号投的，目前1A_1 - INITIAL ASSESSMENT IN PROGRESS，大家投稿状态多久才变？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2361732147, createdName=呆子550, createdTime=Mon Apr 22 16:25:49 CST 2024, time=2024-04-22, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2176797, encodeId=f3fd21e6797fe, content=1A1状态5天了，什么时候能有变化呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=45e52538960, createdName=1251953cm97(暂无昵称), createdTime=Sun Dec 24 08:01:07 CST 2023, time=2023-12-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2239326, encodeId=5fb7223932682, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;放疗 经验分享：17 August 2024 Peer review selection 17 September 2024 First peer reviewer allocated 27 September 2024 First report returned 30 September 2024 Second or more peer reviewer reports returned 11 October 2024 Report sent to the Editor-in-Chief 26 October 2024 Report: revise with changes 31 October 2024 Resubmission pending 13 November 2024 Resubmitted manuscript received 22 November 2024 Processing revised manuscript 22 November 2024 Peer reviewer(s) second round ......审稿一个月，给了3周小修，返回去没几天就Accept。口碑OK，非预警，审稿人非常专业和谨慎，提问细致且内行。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8c171373773, createdName=gzhjjx, createdTime=Tue Nov 26 15:32:47 CST 2024, time=2024-11-26, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2204834, encodeId=958f22048341c, content=偏重的研究方向：临床研究 经验分享：3月26号投的现在还在1A2，大家进度都咋样了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0859239868, createdName=ms9000001639670421, createdTime=Wed May 15 14:40:55 CST 2024, time=2024-05-15, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2210737, encodeId=0a0d2210e3795, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤学 经验分享：大家别投了，一审56天，编辑给我发消息了，我投了1个月还是1A1，想换杂志了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210303/c8f4595dadea4266aa1532bb03641b54/0826761e11894dafafe181f2cae69424.jpg, createdBy=1b7c5246256, createdName=烂医生, createdTime=Thu Jun 20 00:28:44 CST 2024, time=2024-06-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2144927, encodeId=d2e2214492ea2, content=请问大家1a状态持续了3周是为什么啊？2周前收到杂志社邮件说投稿量大，编辑初始审查延长2周，现在2周已经过了，1a一点动静也没有，是为什么呢？有一样的宝子不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7105612032, createdName=ms6000001074362839, createdTime=Tue Jun 27 00:55:47 CST 2023, time=2023-06-27, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2204108, encodeId=047d22041082e, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤;生信 经验分享：审稿慢的要命，我去年年底投的，2月份送审，2月10跟我说第一个意见回来，到现在第二个意见都没回，催稿两次了都是敷衍，已经不想等了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4899118028, createdName=ms6000000944001270, createdTime=Sat May 11 16:03:12 CST 2024, time=2024-05-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2189277, encodeId=a7a521892e76e, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：这个返修回去需要多久有消息呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07ce6584759, createdName=ms4000001373859908, createdTime=Sun Feb 25 14:52:59 CST 2024, time=2024-02-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1075726, encodeId=c02510e5726fa, content=4BD - PROCESSING REVISED MANUSCRIPT这状态三天了，不知道为啥不进行到下一状态，有人知道大修返回去几天能有结果呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=df1d5308328, createdName=雨中龙, createdTime=Wed Dec 01 08:19:50 CST 2021, time=2021-12-01, status=1, ipAttribution=)]

2024-06-20 烂医生来自江苏省

审稿速度:2.0 | 投稿命中率:25.0
偏重的研究方向：肿瘤学
经验分享：大家别投了，一审56天，编辑给我发消息了，我投了1个月还是1A1，想换杂志了

92 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2272515, encodeId=147822e2515db, content=不接收case reports, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Tue Jul 08 14:49:04 CST 2025, time=2025-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2199793, encodeId=3b752199e939f, content=18号投的，目前1A_1 - INITIAL ASSESSMENT IN PROGRESS，大家投稿状态多久才变？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2361732147, createdName=呆子550, createdTime=Mon Apr 22 16:25:49 CST 2024, time=2024-04-22, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2176797, encodeId=f3fd21e6797fe, content=1A1状态5天了，什么时候能有变化呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=45e52538960, createdName=1251953cm97(暂无昵称), createdTime=Sun Dec 24 08:01:07 CST 2023, time=2023-12-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2239326, encodeId=5fb7223932682, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;放疗 经验分享：17 August 2024 Peer review selection 17 September 2024 First peer reviewer allocated 27 September 2024 First report returned 30 September 2024 Second or more peer reviewer reports returned 11 October 2024 Report sent to the Editor-in-Chief 26 October 2024 Report: revise with changes 31 October 2024 Resubmission pending 13 November 2024 Resubmitted manuscript received 22 November 2024 Processing revised manuscript 22 November 2024 Peer reviewer(s) second round ......审稿一个月，给了3周小修，返回去没几天就Accept。口碑OK，非预警，审稿人非常专业和谨慎，提问细致且内行。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8c171373773, createdName=gzhjjx, createdTime=Tue Nov 26 15:32:47 CST 2024, time=2024-11-26, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2204834, encodeId=958f22048341c, content=偏重的研究方向：临床研究 经验分享：3月26号投的现在还在1A2，大家进度都咋样了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0859239868, createdName=ms9000001639670421, createdTime=Wed May 15 14:40:55 CST 2024, time=2024-05-15, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2210737, encodeId=0a0d2210e3795, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤学 经验分享：大家别投了，一审56天，编辑给我发消息了，我投了1个月还是1A1，想换杂志了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210303/c8f4595dadea4266aa1532bb03641b54/0826761e11894dafafe181f2cae69424.jpg, createdBy=1b7c5246256, createdName=烂医生, createdTime=Thu Jun 20 00:28:44 CST 2024, time=2024-06-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2144927, encodeId=d2e2214492ea2, content=请问大家1a状态持续了3周是为什么啊？2周前收到杂志社邮件说投稿量大，编辑初始审查延长2周，现在2周已经过了，1a一点动静也没有，是为什么呢？有一样的宝子不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7105612032, createdName=ms6000001074362839, createdTime=Tue Jun 27 00:55:47 CST 2023, time=2023-06-27, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2204108, encodeId=047d22041082e, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤;生信 经验分享：审稿慢的要命，我去年年底投的，2月份送审，2月10跟我说第一个意见回来，到现在第二个意见都没回，催稿两次了都是敷衍，已经不想等了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4899118028, createdName=ms6000000944001270, createdTime=Sat May 11 16:03:12 CST 2024, time=2024-05-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2189277, encodeId=a7a521892e76e, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：这个返修回去需要多久有消息呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07ce6584759, createdName=ms4000001373859908, createdTime=Sun Feb 25 14:52:59 CST 2024, time=2024-02-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1075726, encodeId=c02510e5726fa, content=4BD - PROCESSING REVISED MANUSCRIPT这状态三天了，不知道为啥不进行到下一状态，有人知道大修返回去几天能有结果呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=df1d5308328, createdName=雨中龙, createdTime=Wed Dec 01 08:19:50 CST 2021, time=2021-12-01, status=1, ipAttribution=)]

2023-06-27 ms6000001074362839 来自湖南省

请问大家1a状态持续了3周是为什么啊？2周前收到杂志社邮件说投稿量大，编辑初始审查延长2周，现在2周已经过了，1a一点动静也没有，是为什么呢？有一样的宝子不

150 7 举报

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2272515, encodeId=147822e2515db, content=不接收case reports, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Tue Jul 08 14:49:04 CST 2025, time=2025-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2199793, encodeId=3b752199e939f, content=18号投的，目前1A_1 - INITIAL ASSESSMENT IN PROGRESS，大家投稿状态多久才变？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2361732147, createdName=呆子550, createdTime=Mon Apr 22 16:25:49 CST 2024, time=2024-04-22, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2176797, encodeId=f3fd21e6797fe, content=1A1状态5天了，什么时候能有变化呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=45e52538960, createdName=1251953cm97(暂无昵称), createdTime=Sun Dec 24 08:01:07 CST 2023, time=2023-12-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2239326, encodeId=5fb7223932682, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;放疗 经验分享：17 August 2024 Peer review selection 17 September 2024 First peer reviewer allocated 27 September 2024 First report returned 30 September 2024 Second or more peer reviewer reports returned 11 October 2024 Report sent to the Editor-in-Chief 26 October 2024 Report: revise with changes 31 October 2024 Resubmission pending 13 November 2024 Resubmitted manuscript received 22 November 2024 Processing revised manuscript 22 November 2024 Peer reviewer(s) second round ......审稿一个月，给了3周小修，返回去没几天就Accept。口碑OK，非预警，审稿人非常专业和谨慎，提问细致且内行。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8c171373773, createdName=gzhjjx, createdTime=Tue Nov 26 15:32:47 CST 2024, time=2024-11-26, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2204834, encodeId=958f22048341c, content=偏重的研究方向：临床研究 经验分享：3月26号投的现在还在1A2，大家进度都咋样了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0859239868, createdName=ms9000001639670421, createdTime=Wed May 15 14:40:55 CST 2024, time=2024-05-15, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2210737, encodeId=0a0d2210e3795, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤学 经验分享：大家别投了，一审56天，编辑给我发消息了，我投了1个月还是1A1，想换杂志了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210303/c8f4595dadea4266aa1532bb03641b54/0826761e11894dafafe181f2cae69424.jpg, createdBy=1b7c5246256, createdName=烂医生, createdTime=Thu Jun 20 00:28:44 CST 2024, time=2024-06-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2144927, encodeId=d2e2214492ea2, content=请问大家1a状态持续了3周是为什么啊？2周前收到杂志社邮件说投稿量大，编辑初始审查延长2周，现在2周已经过了，1a一点动静也没有，是为什么呢？有一样的宝子不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7105612032, createdName=ms6000001074362839, createdTime=Tue Jun 27 00:55:47 CST 2023, time=2023-06-27, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2204108, encodeId=047d22041082e, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤;生信 经验分享：审稿慢的要命，我去年年底投的，2月份送审，2月10跟我说第一个意见回来，到现在第二个意见都没回，催稿两次了都是敷衍，已经不想等了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4899118028, createdName=ms6000000944001270, createdTime=Sat May 11 16:03:12 CST 2024, time=2024-05-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2189277, encodeId=a7a521892e76e, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：这个返修回去需要多久有消息呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07ce6584759, createdName=ms4000001373859908, createdTime=Sun Feb 25 14:52:59 CST 2024, time=2024-02-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1075726, encodeId=c02510e5726fa, content=4BD - PROCESSING REVISED MANUSCRIPT这状态三天了，不知道为啥不进行到下一状态，有人知道大修返回去几天能有结果呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=df1d5308328, createdName=雨中龙, createdTime=Wed Dec 01 08:19:50 CST 2021, time=2021-12-01, status=1, ipAttribution=)]

2024-05-11 ms6000000944001270 来自江苏省

审稿速度:12.0 | 投稿命中率:25.0
偏重的研究方向：肿瘤;生信
经验分享：审稿慢的要命，我去年年底投的，2月份送审，2月10跟我说第一个意见回来，到现在第二个意见都没回，催稿两次了都是敷衍，已经不想等了

86 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2272515, encodeId=147822e2515db, content=不接收case reports, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Tue Jul 08 14:49:04 CST 2025, time=2025-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2199793, encodeId=3b752199e939f, content=18号投的，目前1A_1 - INITIAL ASSESSMENT IN PROGRESS，大家投稿状态多久才变？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2361732147, createdName=呆子550, createdTime=Mon Apr 22 16:25:49 CST 2024, time=2024-04-22, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2176797, encodeId=f3fd21e6797fe, content=1A1状态5天了，什么时候能有变化呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=45e52538960, createdName=1251953cm97(暂无昵称), createdTime=Sun Dec 24 08:01:07 CST 2023, time=2023-12-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2239326, encodeId=5fb7223932682, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;放疗 经验分享：17 August 2024 Peer review selection 17 September 2024 First peer reviewer allocated 27 September 2024 First report returned 30 September 2024 Second or more peer reviewer reports returned 11 October 2024 Report sent to the Editor-in-Chief 26 October 2024 Report: revise with changes 31 October 2024 Resubmission pending 13 November 2024 Resubmitted manuscript received 22 November 2024 Processing revised manuscript 22 November 2024 Peer reviewer(s) second round ......审稿一个月，给了3周小修，返回去没几天就Accept。口碑OK，非预警，审稿人非常专业和谨慎，提问细致且内行。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8c171373773, createdName=gzhjjx, createdTime=Tue Nov 26 15:32:47 CST 2024, time=2024-11-26, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2204834, encodeId=958f22048341c, content=偏重的研究方向：临床研究 经验分享：3月26号投的现在还在1A2，大家进度都咋样了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0859239868, createdName=ms9000001639670421, createdTime=Wed May 15 14:40:55 CST 2024, time=2024-05-15, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2210737, encodeId=0a0d2210e3795, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤学 经验分享：大家别投了，一审56天，编辑给我发消息了，我投了1个月还是1A1，想换杂志了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210303/c8f4595dadea4266aa1532bb03641b54/0826761e11894dafafe181f2cae69424.jpg, createdBy=1b7c5246256, createdName=烂医生, createdTime=Thu Jun 20 00:28:44 CST 2024, time=2024-06-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2144927, encodeId=d2e2214492ea2, content=请问大家1a状态持续了3周是为什么啊？2周前收到杂志社邮件说投稿量大，编辑初始审查延长2周，现在2周已经过了，1a一点动静也没有，是为什么呢？有一样的宝子不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7105612032, createdName=ms6000001074362839, createdTime=Tue Jun 27 00:55:47 CST 2023, time=2023-06-27, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2204108, encodeId=047d22041082e, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤;生信 经验分享：审稿慢的要命，我去年年底投的，2月份送审，2月10跟我说第一个意见回来，到现在第二个意见都没回，催稿两次了都是敷衍，已经不想等了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4899118028, createdName=ms6000000944001270, createdTime=Sat May 11 16:03:12 CST 2024, time=2024-05-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2189277, encodeId=a7a521892e76e, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：这个返修回去需要多久有消息呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07ce6584759, createdName=ms4000001373859908, createdTime=Sun Feb 25 14:52:59 CST 2024, time=2024-02-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1075726, encodeId=c02510e5726fa, content=4BD - PROCESSING REVISED MANUSCRIPT这状态三天了，不知道为啥不进行到下一状态，有人知道大修返回去几天能有结果呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=df1d5308328, createdName=雨中龙, createdTime=Wed Dec 01 08:19:50 CST 2021, time=2021-12-01, status=1, ipAttribution=)]

2024-02-25 ms4000001373859908 来自北京

审稿速度:2.0 | 投稿命中率:75.0
经验分享：这个返修回去需要多久有消息呢？

111 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2272515, encodeId=147822e2515db, content=不接收case reports, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Tue Jul 08 14:49:04 CST 2025, time=2025-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2199793, encodeId=3b752199e939f, content=18号投的，目前1A_1 - INITIAL ASSESSMENT IN PROGRESS，大家投稿状态多久才变？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2361732147, createdName=呆子550, createdTime=Mon Apr 22 16:25:49 CST 2024, time=2024-04-22, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2176797, encodeId=f3fd21e6797fe, content=1A1状态5天了，什么时候能有变化呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=45e52538960, createdName=1251953cm97(暂无昵称), createdTime=Sun Dec 24 08:01:07 CST 2023, time=2023-12-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2239326, encodeId=5fb7223932682, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;放疗 经验分享：17 August 2024 Peer review selection 17 September 2024 First peer reviewer allocated 27 September 2024 First report returned 30 September 2024 Second or more peer reviewer reports returned 11 October 2024 Report sent to the Editor-in-Chief 26 October 2024 Report: revise with changes 31 October 2024 Resubmission pending 13 November 2024 Resubmitted manuscript received 22 November 2024 Processing revised manuscript 22 November 2024 Peer reviewer(s) second round ......审稿一个月，给了3周小修，返回去没几天就Accept。口碑OK，非预警，审稿人非常专业和谨慎，提问细致且内行。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8c171373773, createdName=gzhjjx, createdTime=Tue Nov 26 15:32:47 CST 2024, time=2024-11-26, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2204834, encodeId=958f22048341c, content=偏重的研究方向：临床研究 经验分享：3月26号投的现在还在1A2，大家进度都咋样了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0859239868, createdName=ms9000001639670421, createdTime=Wed May 15 14:40:55 CST 2024, time=2024-05-15, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2210737, encodeId=0a0d2210e3795, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤学 经验分享：大家别投了，一审56天，编辑给我发消息了，我投了1个月还是1A1，想换杂志了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210303/c8f4595dadea4266aa1532bb03641b54/0826761e11894dafafe181f2cae69424.jpg, createdBy=1b7c5246256, createdName=烂医生, createdTime=Thu Jun 20 00:28:44 CST 2024, time=2024-06-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2144927, encodeId=d2e2214492ea2, content=请问大家1a状态持续了3周是为什么啊？2周前收到杂志社邮件说投稿量大，编辑初始审查延长2周，现在2周已经过了，1a一点动静也没有，是为什么呢？有一样的宝子不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7105612032, createdName=ms6000001074362839, createdTime=Tue Jun 27 00:55:47 CST 2023, time=2023-06-27, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2204108, encodeId=047d22041082e, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤;生信 经验分享：审稿慢的要命，我去年年底投的，2月份送审，2月10跟我说第一个意见回来，到现在第二个意见都没回，催稿两次了都是敷衍，已经不想等了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4899118028, createdName=ms6000000944001270, createdTime=Sat May 11 16:03:12 CST 2024, time=2024-05-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2189277, encodeId=a7a521892e76e, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：这个返修回去需要多久有消息呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07ce6584759, createdName=ms4000001373859908, createdTime=Sun Feb 25 14:52:59 CST 2024, time=2024-02-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1075726, encodeId=c02510e5726fa, content=4BD - PROCESSING REVISED MANUSCRIPT这状态三天了，不知道为啥不进行到下一状态，有人知道大修返回去几天能有结果呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=df1d5308328, createdName=雨中龙, createdTime=Wed Dec 01 08:19:50 CST 2021, time=2021-12-01, status=1, ipAttribution=)]

2021-12-01 雨中龙

4BD - PROCESSING REVISED MANUSCRIPT这状态三天了，不知道为啥不进行到下一状态，有人知道大修返回去几天能有结果呀

167 5 举报

展开5条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务